A comparison of heart failure patients with reduced ejection fraction in the Moravian Midlands Registry with the LCZ696 patients in the Paradigm-HF trial.

Pavlu, Ludek; Vicha, Marek; Flasik, Jakub; Petrkova, Jana; Taborsky, Milos; Kacirkova, Tereza; Holy, Ondrej

Pavlu, Ludek; Vicha, Marek; Flasik, Jakub; Petrkova, Jana; Taborsky, Milos; Kacirkova, Tereza; Holy, Ondrej.

Afiliação

Pavlu L; Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Olomouc, Czech Republic.
Vicha M; Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Olomouc, Czech Republic.
Flasik J; Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Olomouc, Czech Republic.
Petrkova J; Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Olomouc, Czech Republic.
Taborsky M; Department of Pathological Physiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic.
Kacirkova T; Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Olomouc, Czech Republic.
Holy O; Science and Research Centre, Faculty of Health Sciences, Palacky University Olomouc, Olomouc, Czech Republic.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub ; 2023 Feb 06.

Article em En | MEDLINE | ID: mdl-36748670

Palavras-chave

MMR; Paradigm HF; heart failure; heart failure with reduced ejection fraction; registry; sacubitril-valsartan; treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google